The US drug safety regulator on Friday warned physicians that drugs used in treating epilepsy, migraine and other conditions carry an increased risk of suicidal thoughts and behaviour.
Patients given anti-epileptics had twice the risk of suicidal thoughts and behaviour (0.43 percent) compared with patients given a placebo (0.22 percent), the Food and Drug Administration (FDA) said in a statement on its website.
The risk corresponds to about two more patients per 1,000 in the drug treatment groups becoming suicidal than in the placebo groups, the FDA said.
http://timesofindia.indiatimes.com/HealthSci/Epilepsy_drugs_up_suicide_risk_Report/articleshow/2750378.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment